| Variable | Category | Frequency (%) |
|---|
| Body Mass Index(kg/m2) | Mean ± SD | 21.5 ± 3.73 |
| Waist circumference | High | 168 (41.3) |
| Normal | 239 (58.7) |
| Waist to hip ratio | High | 305 (74.9) |
| Normal | 102 (25.1) |
| Viral load | Less than 1000 | 369 (90.7) |
| More than 1000 | 38 (9.3) |
| Comorbidity state | Yes | 65 (16) |
| No | 342 (84) |
| WHO clinical stage | Stage I | 403 (99.0) |
| Stage II | 4 (1.0) |
| Opportunistic Infection | Yes | 15 (3.7) |
| No | 392 (96.3) |
| Another drug treatment | Yes | 33 (8.1) |
| No | 374 (91.9) |
| Type of HAART regimen | TDF/3TC/EFV | 186 (45.7) |
| AZT/3TC/NVP | 96 (23.6) |
| TDF/3TC/NVP | 42 (10.3) |
| TDF/3TC/ATV/r | 33 (8.1) |
| AZT/3TC/EFV | 14 (3.4) |
| AZT/3TC/ATV/r | 36 (8.8) |
| Another substance/drug use | Yes | 13 (3.2) |
| No | 394 (96.8) |
| Duration of HIV/AIDS | < 5 years | 77 (18.9) |
| 5–10 years | 178 (43.7) |
| > 10 years | 152 (37.3 |
| Diabetes mellitus | Yes | 36 (8.8) |
| No | 371 (91.2) |
